Punch & Associates Investment Management’s Eli Lilly LLY Stock Holding History

Punch & Associates Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,463	Closed	-$3.18M	–	210
2023 Q4	$3.18M	Sell	5,463 -50	-0.9%	-$29.2K	0.19%	135
2023 Q3	$2.96M	Hold	5,513	–	–	0.19%	140
2023 Q2	$2.59M	Sell	5,513 -3,977	-42%	-$1.67M	0.16%	143
2023 Q1	$3.26M	Sell	9,490 -1,891	-17%	-$638K	0.21%	133
2022 Q4	$4.16M	Buy	11,381 +400	+4%	+$142K	0.27%	124
2022 Q3	$3.55M	Hold	10,981	–	–	0.25%	132
2022 Q2	$3.56M	Hold	10,981	–	–	0.25%	134
2022 Q1	$3.15M	Hold	10,981	–	–	0.18%	148
2021 Q4	$3.03M	Sell	10,981 -87	-0.8%	-$22.1K	0.16%	151
2021 Q3	$2.56M	Buy	11,068 +568	+5%	+$140K	0.15%	161
2021 Q2	$2.41M	Sell	10,500 -388	-4%	-$77.9K	0.14%	166
2021 Q1	$2.03M	Hold	10,888	–	–	0.12%	164
2020 Q4	$1.84M	Hold	10,888	–	–	0.13%	163
2020 Q3	$1.61M	Hold	10,888	–	–	0.14%	163
2020 Q2	$1.79M	Hold	10,888	–	–	0.16%	154
2020 Q1	$1.51M	Buy	+10,888	New	+$1.5M	0.18%	143

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Punch & Associates Investment Management's LLY Position: Q1 2024 in Review

Punch & Associates Investment Management sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 5,463 shares — an estimated $3.18M sold.

Punch & Associates Investment Management first reported a position in LLY in Q1 2020 and held it in 16 quarters. The position peaked at $4.16M in Q4 2022. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

Punch & Associates Investment Management reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
Punch & Associates Investment Management sold 5,463 Eli Lilly shares in Q1 2024, an estimated $3.18M.
Punch & Associates Investment Management first reported a position in Eli Lilly in Q1 2020 and held it in 16 quarters.
Punch & Associates Investment Management's Eli Lilly position peaked at $4.16M in Q4 2022.
3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.